1hu6: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
 
(8 intermediate revisions by the same user not shown)
Line 1: Line 1:
[[Image:1hu6.gif|left|200px]]


<!--
==SOLUTION STRUCTURE OF G10 NOVISPIRIN==
The line below this paragraph, containing "STRUCTURE_1hu6", creates the "Structure Box" on the page.
<StructureSection load='1hu6' size='340' side='right'caption='[[1hu6]]' scene=''>
You may change the PDB parameter (which sets the PDB file loaded into the applet)
== Structural highlights ==
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
<table><tr><td colspan='2'>[[1hu6]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1HU6 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1HU6 FirstGlance]. <br>
or leave the SCENE parameter empty for the default display.
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr>
-->
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1hu6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1hu6 OCA], [https://pdbe.org/1hu6 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1hu6 RCSB], [https://www.ebi.ac.uk/pdbsum/1hu6 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1hu6 ProSAT]</span></td></tr>
{{STRUCTURE_1hu6| PDB=1hu6  |  SCENE= }}
</table>
 
<div style="background-color:#fffaf0;">
'''SOLUTION STRUCTURE OF G10 NOVISPIRIN'''
== Publication Abstract from PubMed ==
 
 
==Overview==
We studied three model antibacterial peptides that resembled the N-terminal 18 amino acids of SMAP-29, an alpha-helical, antimicrobial peptide of sheep. Although the parent compound, ovispirin-1 (KNLRR IIRKI IHIIK KYG), was potently antimicrobial, it was also highly cytotoxic to human epithelial cells and hemolytic for human erythrocytes. Single residue substitutions to ovispirin-1 yielded two substantially less cytotoxic peptides (novispirins), with intact antimicrobial properties. One of these, novispirin G-10, differed from ovispirin-1 only by containing glycine at position 10, instead of isoleucine. The other, novispirin T-7, contained threonine instead of isoleucine at position 7. We determined the three-dimensional solution structures of all three peptides by circular dichroism spectroscopy and two-dimensional nuclear magnetic resonance spectroscopy. Although all retained an amphipathic helical structure in 2,2,2-trifluoroethanol, they manifested subtle fine-structural changes that evidently impacted their activities greatly. These findings show that simple structural modifications can 'fine-tune' an antimicrobial peptide to minimize unwanted cytotoxicity while retaining its desired activity.
We studied three model antibacterial peptides that resembled the N-terminal 18 amino acids of SMAP-29, an alpha-helical, antimicrobial peptide of sheep. Although the parent compound, ovispirin-1 (KNLRR IIRKI IHIIK KYG), was potently antimicrobial, it was also highly cytotoxic to human epithelial cells and hemolytic for human erythrocytes. Single residue substitutions to ovispirin-1 yielded two substantially less cytotoxic peptides (novispirins), with intact antimicrobial properties. One of these, novispirin G-10, differed from ovispirin-1 only by containing glycine at position 10, instead of isoleucine. The other, novispirin T-7, contained threonine instead of isoleucine at position 7. We determined the three-dimensional solution structures of all three peptides by circular dichroism spectroscopy and two-dimensional nuclear magnetic resonance spectroscopy. Although all retained an amphipathic helical structure in 2,2,2-trifluoroethanol, they manifested subtle fine-structural changes that evidently impacted their activities greatly. These findings show that simple structural modifications can 'fine-tune' an antimicrobial peptide to minimize unwanted cytotoxicity while retaining its desired activity.


==About this Structure==
Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides.,Sawai MV, Waring AJ, Kearney WR, McCray PB Jr, Forsyth WR, Lehrer RI, Tack BF Protein Eng. 2002 Mar;15(3):225-32. PMID:11932493<ref>PMID:11932493</ref>
Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1HU6 OCA].


==Reference==
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides., Sawai MV, Waring AJ, Kearney WR, McCray PB Jr, Forsyth WR, Lehrer RI, Tack BF, Protein Eng. 2002 Mar;15(3):225-32. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/11932493 11932493]
</div>
[[Category: Forsyth, W R.]]
<div class="pdbe-citations 1hu6" style="background-color:#fffaf0;"></div>
[[Category: Jr., P B.McCray.]]
== References ==
[[Category: Kearney, W R.]]
<references/>
[[Category: Lehrer, R I.]]
__TOC__
[[Category: Sawai, M V.]]
</StructureSection>
[[Category: Tack, B F.]]
[[Category: Large Structures]]
[[Category: Waring, A J.]]
[[Category: Forsyth WR]]
[[Category: Peptide]]
[[Category: Kearney WR]]
[[Category: Solution structure]]
[[Category: Lehrer RI]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May  2 19:13:56 2008''
[[Category: McCray Jr PB]]
[[Category: Sawai MV]]
[[Category: Tack BF]]
[[Category: Waring AJ]]